Comparative studies of the immunogenicity and protective potential of biofilm vs planktonic Staphylococcus aureus vaccine against bovine mastitis using non-invasive mouse mastitis as a model system

Biofouling

Volumn 31, Issue 7, 2015, Pages 543-554

  Gogoi Tiwari, Jully ^a   Williams, Vincent ^a   Waryah, Charlene Babra ^a   Eto, Karina Yui ^a   Tau, Modiri ^a   Costantino, Paul ^a   Tiwari, Harish Kumar ^b   Mukkur, Trilochan ^a  

^a CURTIN UNIVERSITY   (Australia)

^b MURDOCH UNIVERSITY   (Australia)

Author keywords

biofilm; mouse mastitis model; planktonic; Staphylococcus aureus; vaccine

Indexed keywords

BACTERIAL DISEASE; BACTERIUM; BIOFILM; COLONIZATION; IMMUNE RESPONSE; PLANKTON; RODENT; VACCINATION; VACCINE;

BOVINAE; MUS; STAPHYLOCOCCUS AUREUS;

IMMUNOGLOBULIN G; STAPHYLOCOCCUS VACCINE;

ANIMAL; ANIMAL MODEL; BIOFILM; BOVINE; DRUG EFFECTS; FEMALE; HUMAN; IMMUNOLOGY; MASTITIS, BOVINE; MICROBIOLOGY; MOUSE; PLANKTON; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

ANIMALS; BIOFILMS; CATTLE; FEMALE; HUMANS; IMMUNOGLOBULIN G; MASTITIS, BOVINE; MICE; MODELS, ANIMAL; PLANKTON; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL VACCINES; STAPHYLOCOCCUS AUREUS;

EID: 84941118146     PISSN: 08927014     EISSN: 10292454     Source Type: Journal    
DOI: 10.1080/08927014.2015.1074681     Document Type: Article

References (54)

1. J.C.Anderson, R.L.Chandler. 1975. Experimental staphylococcal mastitis in the mouse: histological, ultrastructural and bacteriological changes caused by a virulent strain of Staphylococcus aureus. J Comp Pathol. 85:499–510.10.1016/0021-9975(75)90117-6
2. J.D.Bancroft, M.Gamble. 2008. Theory and practice of histological techniques. 6th ed. Philadelphia (PA): Churchill Livingstone Elsevier; p. 121–134.
3. H.W.Barkema, Y.H.Schukken, R.N.Zadoks. 2006. Invited review: the role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis. J Dairy Sci. 89:1877–1895.10.3168/jds.S0022-0302(06)72256-1
4. R.Baselga, I.Albizu, M.De La Cruz, E.Del Cacho, M.Barberan, B.Amorena. 1993. Phase variation of slime production in Staphylococcus aureus: implication in colonization and virulence. Infect Immun. 61:4857–4862.
5. C.Beloin, J.Valle, P.Latour-Lambert, P.Faure, M.Kzreminski, D.Balestrino, J.A.J.Haagensen, S.Molin, G.Prensier, B.Arbeille, J.M.Ghigo. 2004. Global impact of mature biofilm lifestyle on Escherichia coli K-12 gene expression. Mol Microbiol. 51:659–674.
6. R.A.Brady, G.A.O’May, J.G.Leid, J.W.Costerton, M.E.Shirtliff. 2011. Resolution of Staphylococcus aureus biofilm infection using vaccination and antibiotic treatment. Infect Immun. 79:1797–1803.10.1128/IAI.00451-10
7. A.L.Clutterbuck, E.J.Woods, D.C.Knottenbelt, P.D.Clegg, C.A.Cochrane, S.L.Percival. 2007. Biofilms and their relevance to veterinary medicine. Vet Microbiol. 121:1–17.10.1016/j.vetmic.2006.12.029
8. R.M.Corrigan, D.Rigby, P.Handly, T.J.Foster. 2007. The role of Staphylococcus aureus surface protein SasG in adherence and biofilm formation. Microbiology. 153:2435–2446.10.1099/mic.0.2007/006676-0
9. C.Cucarella, T.M.Angeles, C.Ubeda, T.M.Pilar, M.Monzon, C.Peris, B.Amorena, I.Lasa, J.S.Penades. 2004. Role of biofilm associated protein Bap in the pathogenesis of bovine Staphylococcus aureus. Infect Immun. 72:2177–2185.10.1128/IAI.72.4.2177-2185.2004
10. C.Cucarella, C.Solano, J.Valle, B.Amorena, I.Lasa, J.R.Penades. 2001. Bap, a Staphylococcus aureus surface protein involved in biofilm formation. J Bacteriol. 183:2888–2896.10.1128/JB.183.9.2888-2896.2001
11. C.Cywes-Bentley, D.Skurnik, T.Zaidi, D.Roux, R.B.Deoliveir, W.S.Garrett, X.Lu, J.O’Malley, K.Kinzel, T.Zaidi,. 2013. Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogens. Proc Natl Acad Sci. 110:E2209–E2218.10.1073/pnas.1303573110
12. S.R.Fry, A.Y.Chen, G.Daggard, T.K.Mukkur. 2008. Parenteral immunization of mice with a genetically inactivated pertussis toxin DNA vaccine induces cell-mediated immunity and protection. J Med Microbiol. 57:28–35.10.1099/jmm.0.47527-0
13. C.Gil, C.Solano, S.Burgni, C.Latasa, B.Garcia, A.Toledo-Arana, I.Lasa, J.Valle. 2014. Biofilm matrix exoproteins induce a protective immune response against Staphylococcus aureus biofilm infection. Infect Immun. 82:1017–1029.10.1128/IAI.01419-13
14. M.I.Gomez, D.O.Sordelli, F.R.Buzzola, V.E.Garci. 2002. Induction of cell-mediated immunity to Staphylococcus aureus in the mouse mammary gland by local immunization with a live attenuated mutant. Infect Immun. 70:4254–4260.10.1128/IAI.70.8.4254-4260.2002
15. J.M.Harro, B.M.Peters, G.A.O’May, N.Archer, P.Kerns, R.Prabhakara, M.E.Shirtliff. 2010. Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration. FEMS Immunol Med Microbiol. 59:306–323.
16. A.Hebert, K.Sayasith, S.Senechal, P.Dubreuil, J.Lagace. 2000. Demonstration of intracellular Staphylococcus aureus in bovine mastitis alveolar cells and macrophages isolated from naturally infected cow milk. FEMS Microbiol Lett. 193:57–62.10.1016/S0378-1097(00)00455-9
17. E.A.Izano, M.A.Amarante, W.B.Kher, J.B.Kaplan. 2008. Differential roles of poly-N-acetylglucosamine surface polysaccharide and extracellular DNA in Staphylococcus aureus and Staphylococcus epidermidis biofilms. Appl Environ Microbiol. 74:470–476.10.1128/AEM.02073-07
18. H.J.Jorgensen, T.Mork, L.M.Rorvik. 2005. The occurrence of Staphylococcus aureus on a farm with small scale production of raw milk cheese. J Dairy Sci. 88:3810–3817.10.3168/jds.S0022-0302(05)73066-6
19. H.K.Kim, A.G.Cheng, H.Y.Kim, D.M.Missiakas, O.Schneewind. 2010. Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice. J Exp Med. 207:1863–1870.10.1084/jem.20092514
20. H.K.Kim, C.Emolo, A.C.DeDent, F.Falugi, D.M.Missiakas, O.Schneewind. 2012. Protein A-specific monoclonal antibodies and prevention of Staphylococcus aureus disease in mice. Infect Immun. 80:3460–3470.10.1128/IAI.00230-12
21. T.Maira-Litran, A.Kropec, D.A.Goldmann, G.B.Pier. 2005. Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated staphylococcal poly-N-acetyl-beta-(1-6)-glucosamine. Infect immun. 73:6752–6762.10.1128/IAI.73.10.6752-6762.2005
22. T.Maitran, A.Kropec-Heubner, D.Goldman, G.Pier. 2004. Biological properties and vaccine potential of the staphylococcal poly-N-glucosamine surface polysaccharide. Vaccine. 22:872–879.10.1016/j.vaccine.2003.11.033
23. W.Mamo, P.Jonsson, J.I.Flock, M.Lindberg. 1994. Vacination against Staphylococcus aureus mastitis: immunological response of mice vaccinated with fibrocetin-binding protein (FnBP-A) to challenge with Staphylococcus aureus. Vaccine. 12:988–992.10.1016/0264-410X(94)90333-6
24. D.McDevitt, P.Francois, P.Vaudaux, T.J.Foster. 1994. Molecular characterisation of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol Microbiol. 11:237–248.10.1111/mmi.1994.11.issue-2
25. D.McKenney, K.L.Pouliot, Y.Wang, V.Murthy. 1999. Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. Science. 284:1523–1527.10.1126/science.284.5419.1523
26. M.B.Melchior, J.Fink-Gremmels, W.Gaastra. 2006. Comparative assessment of the antimicrobial susceptibility of Staphylococcus aureus isolates from bovine mastitis I biofilm versus planktonic culture. J Vet Med B. 53:326–332.10.1111/jvb.2006.53.issue-7
27. N.Merino, A.Toledo-Arana, M.Vergara-Irigaray, J.Valle, C.Solano, E.Calvo, A.J.Lopez, T.J.Foster, J.R.Penades, I.Lasa. 2009. Protein A-mediated multicellular behaviour in Staphylococcus aureus. J Bacteriol. 191:832–843.10.1128/JB.01222-08
28. J.R.Middleton. 2008. Staphylococcus aureus antigen and challenges in vaccine development. Expert Rev Vaccines. 7:805–815.10.1586/14760584.7.6.805
29. T.K.S.Mukkur, B.A.D.Stocker, K.H.Walker. 1991. Genetic manipulation of Salmonella serotype Bovismorbificans to aromatic-dependence and evaluation of its vaccine potential in mice. J Med Microbiol. 34:57–62.10.1099/00222615-34-1-57
30. W.S.Ollet. 1947. A method for staining both Gram positive and Gram negative bacteria in sections. J Pathol Bacteriol. 59:357–358.
31. E.O’Neill, C.Pozzi, P.Houston, D.Smyth, H.Humphreys, D.A.Robinson, A.Loughman, T.J.Foster, J.P.O’Gara. 2008. A novel Staphylococcus aureus biofilm phenotype mediated by the fibronecting-binding proteins, FnBPA and FnBPB. J Bacteriol. 190:3835–3850.10.1128/JB.00167-08
32. J.M.Patti, H.Jonsson, B.Guss, L.M.Switalski, K.Wiberg, M.Lindberg, M.Hook. 1992. Molecular characterisation and expression of a gene encoding of Staphylococcus aureus collagen adhesion. J Biol Chem. 267:1766–1772.
33. U.P.Pereira, D.G.Oliveira, L.R.Mesquita, G.M.Costa, L.J.Pereira. 2011. Efficacy of Staphylococcus aureus vaccines for bovine mastitis: a systematic review. Vet Microbiol. 148:117–124.10.1016/j.vetmic.2010.10.003
34. J.Perez-Casal, T.Prysliak, O.Kerro-Dego, A.A.Potter. 2006. Immune responses to a Staphylococcus aureus GapC/B chimera and its potential use as a component of a vaccine for S. aureus mastitis. Vet Immunol Immunopathol. 109:85–97.10.1016/j.vetimm.2005.07.024
35. M.M.Perez, A.Prenafeta, J.Valle, J.Penades, C.Rota, C.Solano, J.Marco, M.J.Grillo, I.Lasa, J.M.Irache,. 2009. Protection from Staphylococcus aureus mastitis associated with poly-N-acetyl β-1,6 glucosamine specific antibody production using biofilm-embedded bacteria. Vaccine. 27:2379–2386.10.1016/j.vaccine.2009.02.005
36. A.Peschel, M.Otto. 2013. Phenol-soluble modulins and staphylococcal infection. Nat Rev Microbiol. 11:667–673.10.1038/nrmicro3110
37. A.Prenafeta, R.March, A.Foix, I.Casals, L.L.Costa. 2010. Study of the humoral immunological response after vaccination with a Staphylococcus aureus biofilm-embedded bacterin in dairy cows: possible role of the exopolysaccharide specific antibody production in the protection from Staphylococcus aureus induced mastitis. Vet Immun Immunopathol. 134:208–217.10.1016/j.vetimm.2009.09.020
38. C.Prignent-Combaret, O.Vidal, C.Dorel, P.Lejeune. 1999. Abiotic surface sensing and biofilm dependant regulation of gene expression in Escherichia coli. J Bacteriol. 181:5993–6002.
39. A.Resch, S.Leicht, M.Saric, L.Pásztor, A.Jakob, F.Gotz, A.Nordheim. 2006. Comparative proteome analysis of Staphylococcus aureus biofilm and planktonic cells and correlation with transcriptome profiling. Proteomics. 6:1867–1877.10.1002/(ISSN)1615-9861
40. K.C.Rice, E.E.Mann, J.L.Endres, E.C.Weiss, J.E.Cassat, M.S.Smeltzer, K.W.Bayles. 2007. The cidA murein hydrolase regulator contributes to DNA release and biofilm development in Staphylococcus aureus. Proc Natl Acad Sci. 104:8113–8118.10.1073/pnas.0610226104
41. J.R.Roberson, K.L.Fox, D.D.Hancock, J.M.Gay, T.E.Besser. 1998. Sources of intrammmary infections from Staphylococcus aureus in dairy heifers at first parturition. J Dairy Sci. 81:687–693.10.3168/jds.S0022-0302(98)75624-3
42. P.R.Secor, G.A.James, P.Fleckman, J.E.Olerud, K.McInnerney, P.S.Stewart. 2011. Staphylococcus aureus biofilm and planktonic cultures differentially impact gene expression, Mapk phosphorylation, and cytokine production in human keratinocytes. BMC Microbiol. 11:143–153.
43. D.O.Serra, G.Lucking, F.Weiland, S.Schulz, A.Gorg, O.M.Yantorno, M.Ehling-Schulz. 2008. Proteome approaches combined with Fourier transform infrared spectroscopy revealed a distinctive biofilm physiology in Bordetella pertussis. Proteomics. 8:4995–5010.10.1002/pmic.v8:23/24
44. M.Shemesh, A.Tam, D.Steinberg. 2007. Differential gene expression profiling of Streptococcus mutans cultured under biofilm and planktonic conditions. Microbiology. 153:1307–1317.10.1099/mic.0.2006/002030-0
45. D.Skurnik, M.Merighi, M.Grout, M.Gadjeva, T.Maira-Litran, M.Ericsson, D.A.Goldmann, S.S.Huang, R.Datta, J.C.Lee, G.B.Pier. 2010. Animal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice. J Clin Invest. 120:3220–3233.10.1172/JCI42748
46. L.R.Thurlow, M.L.Hanke, T.Fritz, A.Angle, A.Aldrich, S.H.Williams, I.L.Engebretsen, K.W.Bayles, A.R.Horswill, T.Kielian. 2011. Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo. J Immunol. 186:6585–6596.10.4049/jimmunol.1002794
47. L.Timms. 2004. Evaluation of recommended and extended pirlimycin therapy strategies in four high somatic cell count herds. Animal Industry Report. AS 650, ASL R1918. http://lib.dr.iastate.edu/ans_air/vol650/iss1/77.
48. H.Tung, B.Guss, U.Hellman, L.Persson, K.Rubin, C.Ryden. 2000. A bone sialoprotein binding protein from Staphylococcus aureus: a member of the staphylococcal Sdr family. Biochem J. 345:611–619.10.1042/0264-6021:3450611
49. F.W.Twort. 1924. An improved neutral red, light green double stain for staining animal parasites, microorganisms and tissues. J State Med. 32:351–355.
50. C.Vuong, J.M.Voyich, E.R.Fischer, K.R.Braughton, A.R.Whitney, F.R.Deleo, M.Otto. 2004. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell Microbiol. 6:269–275.10.1046/j.1462-5822.2004.00367.x
51. R.D.Waite, A.Papakonstantinopoulou, E.Littler, M.A.Curtis. 2005. Transcriptome analysis of Pseudomonas aeruginosa growth: comparison of gene expression in planktonic cultures and developing and mature biofilms. J Bacteriol. 187:6571–6576.10.1128/JB.187.18.6571-6576.2005
52. Y.Yao, D.E.Sturdevant, M.Otto. 2005. Genomewide analysis of gene expression in Staphylococcus epidermidis biofilms: insights into the pathophysiology of S. epidermidis biofilms and the role of phenol-soluble modulins in formation of biofilms. J Infect Dis. 191:289–298.10.1086/jid.2005.191.issue-2
53. A.Zecconi, F.Scali. 2013. Staphylococcus aureus virulence factors in evasion from innate immune defenses in human and animal diseases. Immunol Lett. 150:12–22.10.1016/j.imlet.2013.01.004
54. H.Zhou, Z.Y.Xiong, H.LIHP, Y.L.Zheng, Y.Q.Jiang. 2006. An immunogenicity study of a newly fusion protein Cna-FnBP vaccinated against Staphylococcus aureus infections in a mice model. Vaccine. 24:4830–4837.10.1016/j.vaccine.2006.03.020